Breaking News

Medical journal receives U.S. attorney letter seeking info about alleged bias

April 18, 2025
President Trump has argued pharma tariffs will help incentivize drugmakers to move production facilities to the U.S.
Adobe

STAT+ | How to think about Trump's pharma tariffs — before they hit

There are a host of factors to consider when assessing what the levies will mean for both drugmakers and consumers.

By Ed Silverman


White House trumpets Covid lab leak theory on web page that was devoted to health information

A government website long used for Covid-19 guidance is replaced with a page promoting the disputed Wuhan lab leak origin theory, alleged Fauci coverup.

By Jason Mast


STAT+ | Makary says FDA will remove pharma representatives from advisory panels

Representatives from pharma and other industries already play a more limited role in advising the FDA.

By John Wilkerson



Trump's AI strategy focuses on innovation, deregulation, and growth — a sharp contrast with Biden's emphasis on risk, safety and algorithmic bias.
Anna Moneymaker/Getty Images

STAT+ | In directives to federal agencies, Trump charts a different course for AI

Trump's AI strategy focuses on innovation, deregulation, and economic growth, a sharp break from Biden-era emphasis on risk, safety and algorithmic bias.

By Casey Ross and Brittany Trang


STAT+ | Health care industry, worried millions could lose ACA insurance, pushes for Trump to delay changes

Hospitals and health insurers are alarmed at the prospect of an increase in the number of people without health insurance.

By Bob Herman


Opinion: I don't know what I'm supposed to call my rare kidney disease

I don't know my disease's name definitively, and it's not because my diagnosis changed. It's become the subject of intense debate.

By Taylor Coffman


Adobe

STAT+ | Medical journal receives U.S. attorney letter seeking information about alleged bias

Scientific journals questioned about alleged bias. Legal experts say U.S. Attorney Ed Martin exceeded his authority with "ham-handed" intimidation tactic.

By Anil Oza


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments